Intra-Cellular Therapies (ITCI) Stock Forecast

Intra-Cellular Therapies

Healthcare · USD · United States

TG WA X in ⧉

Last price—

Change—

AI forecast: ITCI

There is no current AI forecast for this stock.

The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.

Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.

Unlock Premium

About This Company

Intra -Cellular Therapies is a biopharmaceutical company based on the study of the Gringer Gringer, which received the Nobel Prize, which revealed how the methods of treatment affect the internal functioning of cells in the body.

Related Stocks

TXG10X Genomics Inc Last price$59.20 +2.30%AI forecast · 1 day🔒 Premium ABTAbbott Last price$109.96 -3.17%AI forecast · 1 day🔒 Premium ABBVAbbVie Last price$291.31 +1.07%AI forecast · 1 day🔒 Premium ABCLAbCellera Biologics Last price$11.89 +7.02%AI forecast · 1 day🔒 Premium ACADACADIA Pharmaceuticals Inc Last price$21.22 -0.56%AI forecast · 1 day🔒 Premium ACMRACM Research Inc Last price$44.64 +13.82%AI forecast · 1 day🔒 Premium ADAPAdaptimmune Therapeutics ADR Last price$0.02 0.00%AI forecast · 1 day🔒 Premium ADPTAdaptive Biotechnologies Last price$27.97 +4.37%AI forecast · 1 day🔒 Premium

Disclaimer: AI-generated stock predictions are for informational purposes only and do not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions. Investing involves risk, including possible loss of principal.